SERPINF1 and metabolic syndrome: However, these studies focused solely on subjects with CAD risk factors but no clinical evidence of cardiovascular disease, which may have limited their ability to extend this relation of serum PEDF with MetS to the subsequent onset of cardiovascular disease.